Atlas Trials

A Study Evaluating the Safety and Efficacy of Hormone Replacement Therapy With ST-1891 Compared to Levothyroxine in Patients With Primary Hypothyroidism

Clinical trial NCT05412979 · COMPLETED

Trial details

NCT number
NCT05412979
Sponsor
Sention Therapeutics, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypothyroidism
Start date
2022-04-29
Primary completion
2023-10-04
Enrollment
490

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.